"PROGRESS IS NOT ONLY ABOUT HOW WE GROW.
IT IS ABOUT HOW WE MAKE A DIFFERENCE
IN THE LIVES OF OTHERS
!"

That's the guiding principal of Serum Institute of India Ltd., India's No. 1 Biotech Company and the World's 5th largest vaccine manufacturer (by volume) with an installed capacity of over 1 billion doses of different vaccines. We are also one of the largest suppliers of vaccines to over a 130 countries and take pride at the fact that 1  out of every 2 children immunized worldwide gets at least one vaccine produced by Serum Institute.

Serum Institute was founded by a true visionary Dr. Cyrus S. Poonawalla, to ensure that vaccines do not remain a luxury for children in India. Having achieved this goal, Serum Institute started supplies of high quality, yet affordable vaccines to several countries around the world. The impact has been large enough to make International agencies such as WHO, PATH, NIH, NVI/RIVM and CBER/USFDA to work with Serum Institute to develop vaccines against Meningococcal A, H1Ni Influenza, Rotavirus and other diseases. It is the mission of Serum Institute to develop quality vaccines and offer them at inexpensive prices, thus facilitating several countries to improve their Health Index.

Though Serum Institute has grown manifold, its achievements and philanthropical nature acknowledged, the original goal of making available World-Class vaccines at affordable prices remains intact and is the soul of the Organization.


 
Launched H1N1 influenza vaccine (live) - Nasovac, liquid pentavalent vaccine in pre-filled syringes - Pentavac PFS, IPV Poliovac PFS, and r-EPO - Repoitin in pre-filled syringes.
Launched liquid pentavalent vaccine - Pentavac SD/MD.
 Recognized as India's No. 1 Bio-tech company for the 4th consecutive year.
Launched combi-pack of pentavalent vaccine - Pentavac and quadravalent vaccine, Quadrovax. Recognized as India's No. 1 Bio-tech company for the 3rd consecutive year.
Recognized as India's No. 1 Bio-tech company for the 2nd consecutive year. Launched Hib vaccine - Sii HibPro and BCG vaccine for Bladder cancer - Sii-ONCO-BCG.
Recognized as the No. 1 Bio-tech company in India.
Launched indigenously developed DTP-HB Combination vaccine -  SII Q-VAC.
Launched the World's only adsorbed liquid HDC Rabies vaccine -  SII Rabivax.
Launched BCG vaccine.
Launched indigenously manufactured Hepatitis-B vaccine (rDNA)  - GeneVac-B.

One out of every two children in the world vaccinated by Serum Institute’s vaccine.
Serum Institute recognized as the World's largest producer of Measles and DTP group of vaccines.

Export of vaccines crossed over a 100 countries.
Commencement of export of vaccines to UN agencies.
Launched India's first MMR Vaccine - Tresivac
Manufacture of Rubella virus vaccine (monovalent Rubella vaccine) for the first time in India.
Manufacture of M-Vac (Measles Vaccine) using E-Z Strain of virus on Human Diploid Cells.
Manufacture of life-saving Polyvalent Anti-Snake Venom Serum effective against four poisonous snakes encountered in India.
Serum Institute of India Research Foundation; Autonomous scientific wing established.
Triple Antigen (Diphtheria-Tetanus-Pertussis) Vaccine production commenced.
Large-scale manufacture of Adsorbed Tetanus Toxoid undertaken.
Operations began with manufacture of Tetanus Antitoxin followed by Tetanus Toxoid.  


Copyright 2012 Serum Institute of India Limited. Legal Disclaimer.